Building on a 25+ year partnership, the companies will each provide one of the largest hemostasis testing system and reagent portfolios to laboratories. Under the multi-year agreement, both companies will individually distribute their combined portfolio of hemostasis instruments and reagents worldwide under their respective own brands.

Making clinical proteomics 100x more robust and 10x faster   Evosep aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. We will make sample preparation and separation for MS analysis 10 times faster and 100 times more robust in order to enable truly large cohort studies and provide […]

It is critical to strengthen laboratories to enable more people to access quality testing and build stronger, resilient healthcare systems Public-private partnerships contribute to strengthening laboratory systems by leveraging the respective strengths, experience, and resources of the partners About 2 billion people worldwide are estimated to be infected with tuberculosis and more than 38 million […]